KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,725,000 | +10.0% | 294,398 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $1,568,000 | -20.0% | 295,306 | -0.3% | 0.00% | 0.0% |
Q2 2016 | $1,960,000 | +20.0% | 296,076 | -15.4% | 0.00% | 0.0% |
Q1 2016 | $1,634,000 | -6.1% | 349,878 | +1.6% | 0.00% | 0.0% |
Q4 2015 | $1,740,000 | +43.7% | 344,472 | +0.2% | 0.00% | 0.0% |
Q3 2015 | $1,211,000 | -65.3% | 343,897 | -1.6% | 0.00% | -50.0% |
Q2 2015 | $3,489,000 | -2.0% | 349,565 | +25.0% | 0.00% | -20.0% |
Q1 2015 | $3,559,000 | +1.1% | 279,608 | +12.4% | 0.01% | 0.0% |
Q4 2014 | $3,521,000 | +2.3% | 248,814 | -0.6% | 0.01% | 0.0% |
Q3 2014 | $3,441,000 | -10.6% | 250,255 | +0.0% | 0.01% | 0.0% |
Q2 2014 | $3,847,000 | -8.3% | 250,130 | +1.6% | 0.01% | -16.7% |
Q1 2014 | $4,194,000 | +44.2% | 246,129 | +9.6% | 0.01% | +50.0% |
Q4 2013 | $2,909,000 | +25.0% | 224,609 | -2.7% | 0.00% | 0.0% |
Q3 2013 | $2,328,000 | +42.7% | 230,772 | +5.7% | 0.00% | +33.3% |
Q2 2013 | $1,631,000 | – | 218,353 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |